|
Laraine Meyers served most recently as Director, Regulatory Affairs at Vertex Pharmaceuticals Incorporated, providing regulatory strategy as well as compliance and submission guidance for early development of drug candidates. From 1999 to 2004, Dr. Meyers was an Associate Director in the Regulatory Affairs Department at Pfizer Central Research where she advised on regulatory policy, strategy, submission and registration for early drug candidates and full development drug products including Celebrex and Bextra. Between 1993 to 1998, Dr. Meyers held multiple positions at the Food and Drug Administration, Center for Drug Evaluation and Research, including the evaluation and supervision of programs and activities related to the discipline of Pharmacology and Toxicology. She received her undergraduate (pharmacy), master’s (pathobiology) and doctoral (pharmacology and toxicology) degrees from the University of Connecticut. | 